Zestril
Zestril
- Zestril (lisinopril) is stocked in community pharmacies, hospitals and licensed online pharmacies across Canada and internationally; officially it is a prescription-only medicine, though in some pharmacies or online outlets it may be sold without a receipt or prescription—always check local regulations and pharmacy policies before purchase.
- Zestril is used to treat hypertension, heart failure and to improve outcomes after myocardial infarction; it is an ACE inhibitor that blocks angiotensin‑converting enzyme, reducing formation of angiotensin II and aldosterone, which lowers blood pressure and reduces cardiac workload.
- Usual dosages: for adult hypertension start 10 mg once daily (titrate as needed up to 40 mg once daily); heart failure initial 5 mg once daily (up to 40 mg); post‑MI dosing often begins with 5 mg then increased to 10 mg daily; pediatric dosing (≥6 years and ≥20 kg) is lower or weight‑based (typically 2.5–5 mg or ~0.07 mg/kg starting, max ~0.6 mg/kg up to 40 mg).
- Administered orally as tablets (commonly 2.5, 5, 10, 20, 30 and 40 mg) or as an oral solution (1 mg/mL Qbrelis formulation).
- Zestril begins to lower blood pressure within about 1 hour of dosing, with peak effect around 6–8 hours after administration.
- The antihypertensive effect typically lasts about 24 hours (allowing once‑daily dosing); the elimination half‑life is roughly 12 hours.
- Avoid or limit alcohol while taking Zestril, as alcohol can increase the risk of dizziness and symptomatic low blood pressure (especially when starting therapy or after dose changes).
- The most common side effect is a persistent dry cough.
- Would you like to try zestril without a prescription?
Basic Zestril Information
- INN (International Nonproprietary Name): lisinopril.
- Brand Names Available In Canada (English): Prinivil and generics labelled as Lisinopril are commonly available in Canada; Zestril and Qbrelis are known international brands and formulations.
- ATC Code: C09AA03 (Cardiovascular system; Agents acting on the renin-angiotensin system; ACE inhibitors, plain; lisinopril specifically).
- Forms & Dosages: Tablets in 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg strengths; oral solution 1 mg/mL (Qbrelis, mainly US market).
- Manufacturers In Canada (English): Prinivil is the commonly encountered brand in Canada; generics are supplied by manufacturers such as Teva, Sandoz and Mylan in global markets.
- Registration Status In Canada (English): Lisinopril products such as Prinivil are registered and marketed for prescription use in Canada; registration details should be confirmed with Health Canada and provincial formularies.
- OTC / Rx Classification: Prescription only (Rx) in Canada and other major markets.
Latest Research Highlights (Canadian & International 2022–2025)
Worried that new studies have changed how lisinopril performs in real life?
Recent Canadian cohort analyses and international meta-analyses continue to support the role of ACE inhibitors such as lisinopril in lowering blood pressure and improving cardiovascular outcomes in indicated patients.
Canadian registry data emphasise better outcomes when ACE inhibitors are started early after myocardial infarction, with observational analyses showing fewer heart-failure admissions in treated cohorts.
Regulatory pharmacovigilance summaries from major authorities list cough, hyperkalaemia and changes in renal function as the most reported safety signals for ACE inhibitors.
Implementation research from Canada points to adherence barriers including cost, polypharmacy and rural pharmacy access, and highlights benefits from single-pill combinations and pharmacist-led follow-up programs.
Clinical translation cautions clinicians to reconcile trial populations with older, multimorbid Canadians who have higher chronic kidney disease and polypharmacy prevalence.
| Endpoint | Reported Value |
|---|---|
| Average BP Drop (mmHg) | Not specified |
| Relative Risk Reduction For Heart Failure/Mortality | Not specified |
| Common Adverse Event Rates (Cough, Hyperkalaemia) | Not specified |
Data Highlight: Pooled effect sizes and precise pooled estimates are not specified in the source data provided here.
- Top Canadian Studies (examples for editors): recent post‑MI cohort analyses 2022–2025, provincial registry studies on ACE inhibitor initiation, and primary-care adherence evaluations with pharmacist interventions.
- Key International Meta-Analyses: class-level ACE inhibitor meta-analyses, cardiovascular outcomes meta-analyses, and pharmacovigilance summaries from EMA/FDA.
Clinical Effectiveness In Canada
Want to know how well lisinopril works for common Canadian patients?
Health Canada product monographs and provincial formularies list lisinopril products such as Prinivil for hypertension, heart failure and post-myocardial infarction management.
Canadian observational data mirror international findings showing effective blood pressure control and reductions in heart-failure admissions where ACE inhibitors are used appropriately.
Dispensing pharmacists should check the product monograph and the drug identification number (DIN) when dispensing to confirm exact formulation and strength.
Many provinces include lisinopril on their core formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ, though coverage rules and special-authorisation requirements differ by province.
Pharmacists at major chains and independent pharmacies commonly provide medication reviews and can enrol eligible patients in provincial adherence programs.
- Monitoring Endpoints: blood pressure, serum creatinine, serum potassium.
- Practical Tip For Prescribers: document the indication clearly on the prescription to align with provincial formulary criteria.
- DIN
- Drug Identification Number used to identify the exact product for dispensing.
- NOC
- Notice of Compliance or other regulatory term used in Canadian registration contexts.
- HC Monograph
- Health Canada product monograph containing dosing, safety and regulatory information.
Indications And Expanded Uses (Approved Versus Off-Label In Canadian Practice)
Are there situations where lisinopril is used beyond its primary approvals?
Health Canada and other regulators list lisinopril for hypertension, heart failure and post-myocardial infarction care.
Paediatric dosing is established for children aged six years and older with weight-based recommendations.
Real-world Canadian practice frequently uses ACE inhibitors off-label to reduce proteinuria in chronic kidney disease, including diabetic nephropathy, because they lower albuminuria and can slow progression when monitored carefully.
- Approved Indications: Hypertension, Heart Failure, Post-Myocardial Infarction.
- Common Off-Label Uses: Proteinuric Chronic Kidney Disease (diabetic nephropathy), select low-renin hypertension cases.
| Indication | Typical Starting Dose | Usual Maximum |
|---|---|---|
| Hypertension (Adults) | 10 mg once daily | 40 mg once daily |
| Heart Failure (Adults) | 5 mg once daily | 40 mg once daily |
| Post-Myocardial Infarction | 5 mg initially, then titration to 10 mg daily per monograph | 10 mg once daily (monograph regimen) |
Patient Caveat: Pregnancy is an absolute contraindication; reproductive-age patients must be counselled and alternatives considered.
Pediatric Note: For children ≥6 years the recommended initial dosing is weight-based, starting around 0.07 mg/kg as guidance; not recommended for children under 6 years.
Renal Impairment: For CrCl <30 mL/min consider starting at 2.5 mg daily and titrating with close monitoring.
Composition And Brand Landscape In Canada And Abroad
Which brands and forms of lisinopril will my pharmacy stock?
Lisinopril is marketed globally under brand names including Zestril, Prinivil, and numerous generics from manufacturers such as Teva, Sandoz and Mylan.
In Canada, Prinivil and generic-labelled lisinopril tablets are commonly encountered, while Qbrelis oral solution is mainly distributed in the US market.
| Brand | Form | Strengths | Typical Packaging |
|---|---|---|---|
| Prinivil | Tablet | 2.5–40 mg | Blisters or bottles, 28–100 tablets |
| Zestril | Tablet | 2.5–40 mg | Blisters or bottles, 28–100 tablets |
| Qbrelis | Oral solution | 1 mg/mL | 150 mL bottle (mainly US) |
- Major Manufacturers: AstraZeneca and Merck originally; generics by Teva, Sandoz, Mylan and others.
- Patient Note: Pharmacists can show the DIN and manufacturer if a patient requests brand-name continuity rather than substitution.
- INN
- International Nonproprietary Name: lisinopril.
- DIN
- Unique identifier for the specific marketed product in Canada.
- ATC
- Classification code C09AA03 for lisinopril.
Contraindications And Special Precautions (Canadian Safety Framing)
What are the absolute no-go situations for lisinopril?
Absolute contraindications include a history of ACE-inhibitor–related angioedema, pregnancy and concomitant use with sacubitril/valsartan within 36 hours.
Relative contraindications requiring close monitoring include renal artery stenosis, severe renal impairment and risk of hyperkalaemia with potassium-sparing agents.
In Canada, clinicians should be mindful of older adults and Indigenous populations who have higher CKD prevalence and may face barriers to timely laboratory monitoring.
- Immediate Red-Flag Symptoms: facial or tongue swelling, severe dizziness, fainting, marked oliguria.
- Baseline Tests To Obtain: serum creatinine and potassium prior to initiation.
| Risk Category | Monitoring Frequency |
|---|---|
| Standard Risk | Baseline, 1–2 weeks after start, then as clinically indicated |
| High Risk (CKD, Concomitant K-Raising Drugs) | Baseline, 1 week, then frequent monitoring until stable |
Clinician Guidance: Document pregnancy counselling and consider bilingual consent and counselling materials where appropriate.
Dosage Guidelines — Canadian Practice And Adjustments
How should dosing be adjusted for older adults and people with kidney disease?
Adults with hypertension typically start at 10 mg once daily with a usual maximum of 40 mg once daily according to product monographs.
Heart failure and post-MI regimens commonly start at lower doses such as 5 mg with careful titration.
Because lisinopril is renally excreted, reduce the initial dose to 2.5 mg/day for patients with CrCl <30 mL/min and titrate cautiously.
Elderly patients should start at lower doses and be monitored for hypotension.
| Population | Starting Dose | Notes |
|---|---|---|
| Adult Hypertension | 10 mg once daily | Max 40 mg daily; titrate by response |
| Heart Failure / Post-MI | 5 mg once daily | Careful up-titration to tolerated dose |
| Renal Impairment (CrCl <30 mL/min) | 2.5 mg once daily | Increase slowly with monitoring |
| Pediatrics (≥6 Years) | Weight-based (start ~0.07 mg/kg) | Not recommended <6 years |
- Titration Steps: start low, recheck BP and labs at 1–2 weeks, adjust dose every 1–2 weeks as needed.
- Patient Instructions: take once daily at the same time; if a dose is missed take when remembered unless near the next dose and do not double doses.
Pharmacist Action: record baseline BP, creatinine and potassium and schedule first follow-up within 1–2 weeks of initiation or dose change.
Interactions Overview — Food, Drugs, And Canadian Lifestyle Factors
Which medicines and lifestyle choices can change how lisinopril works?
Major pharmacologic interactions include potassium-sparing diuretics and supplements, NSAIDs, ARBs, and sacubitril/valsartan (observe a 36-hour washout rule when switching to or from sacubitril/valsartan).
Mechanistically, NSAIDs combined with ACE inhibitors may reduce renal perfusion and blunt antihypertensive effects while increasing kidney injury risk.
Lifestyle interactions to flag include use of potassium-containing salt substitutes, certain herbal supplements and excessive alcohol which may amplify hypotension or hyperkalaemia risks.
- Common Counselling Points: avoid starting potassium supplements without lab confirmation; avoid chronic NSAID use without clinician oversight.
- Action For Rural/Elderly Patients: pharmacists should ask about OTC NSAID use and provide point-of-sale counselling at chains and independent stores.
| Interaction | Severity | Monitoring / Advice |
|---|---|---|
| Potassium-Sparing Diuretics / Supplements | High | Check potassium; avoid supplements unless indicated |
| NSAIDs | Moderate to High | Monitor renal function; counsel on limiting use |
| Sacubitril/Valsartan | High | Maintain a 36-hour interval when switching |
Cultural Perceptions And Patient Habits In Canada
How do Canadian patients typically feel about lisinopril and its alternatives?
Community feedback and pharmacy consultations indicate strong trust in public healthcare, a preference for generics to reduce costs, and concern about teratogenic risks among reproductive-age patients.
Rural patients commonly face longer refill intervals and restricted lab access, which can complicate safe monitoring for ACE inhibitor therapy.
Indigenous communities often have higher rates of diabetes and CKD, increasing the need for close monitoring and culturally safe counselling.
| Setting | Access Difference |
|---|---|
| Urban | Shorter lab turnaround; more pharmacies and telehealth options |
| Rural | Longer lab waits; limited pharmacy hours; telepharmacy may be needed |
- Bilingual Needs: English/French labelling and counselling improve adherence in many provinces.
- Pharmacist Roles: medication reviews, adherence packs and culturally sensitive counselling increase treatment success.
Availability And Pricing Patterns Across Canada And Cross-Border Notes
Where can patients get lisinopril and how much will it cost them?
Prinivil and generic lisinopril tablets in strengths from 2.5 mg to 40 mg are widely available at major chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs and at independent pharmacies.
Generics are typically less costly and are commonly listed on provincial formularies, but exact patient cost depends on the provincial plan or private insurance.
In our online pharmacy, zestril is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
- Steps To Obtain Coverage: confirm DIN on the prescription, submit to provincial plan, and request special authorisation if required.
- Cross-Border Note: travellers should verify importation rules and avoid bringing prescription medicines without proper documentation and conforming to customs rules.
| Supplier Type | Availability | Strengths |
|---|---|---|
| Major Chains | Widespread | 2.5–40 mg tablets |
| Independent Pharmacies | Widespread | 2.5–40 mg tablets |
| Online Pharmacies | Available with prescription verification or pharmacy account | 2.5–40 mg tablets |
Comparable Medicines And Patient Preferences
What are reasonable alternatives if lisinopril is not suitable?
Alternatives include other ACE inhibitors such as enalapril, ramipril and perindopril, and angiotensin receptor blockers such as losartan and valsartan for patients who develop cough or angioedema.
Comparative evidence at class level shows similar blood pressure lowering and cardiovascular outcome benefits across ACE inhibitors and ARBs, with tolerability and pharmacokinetics guiding selection.
| Drug | Typical Starting Dose | Common Side Effects |
|---|---|---|
| Enalapril | 5 mg once daily (example) | Cough, dizziness, hyperkalaemia |
| Ramipril | 2.5 mg once daily (example) | Cough, hypotension, renal function changes |
| Losartan (ARB) | 50 mg once daily (example) | Dizziness, hyperkalaemia; lower cough risk |
- ACEI Versus ARB Pros/Cons: ARBs are often used when ACE inhibitors cause cough or angioedema; cost and formulary coverage influence choice.
- Pharmacist Role: document prior ACEI intolerance and support ARB substitution pathways when clinically indicated.
FAQ: Canadian Patient Questions And Plain Answers
Have quick questions about safety, pregnancy or monitoring?
- Can I get Zestril without a prescription in Canada? No; lisinopril is generally prescription-only and dispensing is tracked via DIN, though some online pharmacy services advertise different access models.
- Is lisinopril safe if I’m pregnant or planning pregnancy? No; ACE inhibitors are contraindicated during pregnancy and alternatives should be discussed prior to conception.
- What if I develop a cough? A persistent dry cough can occur; contact your prescriber—switching to an ARB is commonly recommended if cough is bothersome.
- How often should labs be done? Obtain baseline labs and repeat within 1–2 weeks of starting or changing dose, then periodically according to kidney risk.
- Can I drive after starting? Dizziness or hypotension can occur; avoid driving until you know how lisinopril affects you.
Data Highlight: Absolute contraindications include prior ACE-inhibitor angioedema, pregnancy and concurrent sacubitril/valsartan use within 36 hours.
Guidelines For Proper Use — Pharmacist And Provincial Authority Tips
What checklist should pharmacists and prescribers follow before starting lisinopril?
Follow a pre-initiation checklist that includes verifying indication, checking blood pressure, reviewing medications for interactions and measuring serum creatinine and potassium.
| Monitoring Point | Recommended Timing |
|---|---|
| Baseline BP, Creatinine, Potassium | Before initiation |
| Early Follow-Up | 1–2 weeks after start or dose change |
| Short-Term Review | 1–3 months |
| Ongoing | Annually or as clinically indicated |
- Pharmacist Actions: document the DIN, offer blister packs or adherence packaging, and notify provincial drug plans for special authorisations.
- Remote/Rural Tip: use telepharmacy and coordinate with local labs for draws to ensure timely monitoring.
Storage Tip: store lisinopril tablets at room temperature, roughly 15–30°C, and keep in original packaging to limit humidity exposure.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Hamilton | Ontario | 5-7 days |
| Quebec City | Quebec | 5-9 days |
| Halifax | Nova Scotia | 5-9 days |
| London | Ontario | 5-7 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
Final Practical Notes
When counselling a patient, always confirm the exact product by DIN and strength.
Remind reproductive-age patients about teratogenic risk and document pregnancy counselling in the patient record.
Encourage patients to bring all medications including OTCs and supplements to medication reviews to check for interactions such as potassium supplements and NSAIDs.
If a patient reports cough or angioedema, instruct them to stop the medication and seek immediate medical advice.
For prescribers and pharmacists, align documentation with provincial formulary requirements and use adherence supports such as blister packs and pharmacist follow-ups to improve outcomes.